UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

AIDS (London), 2006-06, Vol.20 (9), p.F9-F13

2006

Volltextzugriff (PDF)

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

Journal of Virology, 2009-02, Vol.83 (4), p.2029-2033

2009

Volltextzugriff (PDF)

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment

Pathogens & immunity, 2024-08, Vol.9 (2), p.58-78

2024

Volltextzugriff (PDF)

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

The Journal of infectious diseases, 2009-10, Vol.200 (8), p.1202-1206

2009

Volltextzugriff (PDF)

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Journal of Virology, 2002-02, Vol.76 (4), p.1753-1761

2002

Volltextzugriff (PDF)

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2087-2094

2002

Volltextzugriff (PDF)

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Clinical infectious diseases, 2019-08, Vol.69 (4), p.676-686

2019

Volltextzugriff (PDF)

Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

Antimicrobial Agents and Chemotherapy, 2004-11, Vol.48 (11), p.4189-4194

2004

Volltextzugriff (PDF)

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2022-01, Vol.74 (1), p.95-104

2022

Volltextzugriff (PDF)

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2023-07, Vol.77 (2), p.272-279

2023

Volltextzugriff (PDF)

HIV post-treatment controllers have distinct immunological and virological features

Proceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (11), p.e2218960120

2023

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionResearch in context

EBioMedicine, 2023-03, Vol.89, p.104468

2023

Volltextzugriff (PDF)

Association of Soluble Markers of Inflammation With Pericoronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Open forum infectious diseases, 2023-08, Vol.10 (8)

2023

Volltextzugriff (PDF)

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Journal of medical virology, 2011-05, Vol.83 (5), p.751-759

2011

Volltextzugriff (PDF)

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

Pathogens & immunity, 2024-08, Vol.9 (2)

2024

Volltextzugriff (PDF)

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.1115-1119

2011

Volltextzugriff (PDF)

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Open forum infectious diseases, 2017-01, Vol.4 (1), p.ofw278-ofw278

2017

Volltextzugriff (PDF)

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Open forum infectious diseases, 2023-02, Vol.10 (2), p.ofad063-ofad063

2023

Volltextzugriff (PDF)

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad328-ofad328

2023

Volltextzugriff (PDF)

Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239

Journal of virology, 2015-12, Vol.89 (23), p.12002-12013

2015

Volltextzugriff (PDF)

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab245-ofab245

2021

Volltextzugriff (PDF)

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

Antiviral chemistry & chemotherapy, 2004-10, Vol.15 (5), p.255-259

2004

Volltextzugriff (PDF)

HIV‐1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV‐1 group M

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19738-n/a

2014

Volltextzugriff (PDF)

Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitor

Antimicrobial agents and chemotherapy, 2007, Vol.51 (2), p.604-610

2007

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Humans
(15)
Infectious Diseases
(15)
Life Sciences & Biomedicine
(15)
Microbiology
(14)
Immunology
(12)
Hiv
(11)
Human Immunodeficiency Virus 1
(11)
Hiv-1 - Genetics
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(8)
Virology
(8)
Hiv-1 - Classification
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Hiv Infections - Drug Therapy
(6)
Hiv Reverse Transcriptase - Genetics
(6)
Inflammation
(6)
Major
(6)
Anti-Hiv Agents - Pharmacology
(5)
Drug Resistance
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

HIV post-treatment controllers have distinct immunological and virological features

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionResearch in context

Association of Soluble Markers of Inflammation With Pericoronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

HIV‐1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV‐1 group M

Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitor

Aktive Filter

Suchergebnisse filtern